Assertio Therapeutics, Inc. (ASRT) financial statements (2020 and earlier)

Company profile

Business Address 100 SOUTH SAUNDERS RD
LAKE FOREST, IL 60045
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments54111128177210559272
Cash and cash equivalents54111127118101489245
Short-term investments  1601097127
Receivables433772102712711
Inventory, net of allowances, customer advances and progress billings33131310810
Inventory33131310810
Deferred tax assets    1027
Other undisclosed current assets23571814181317
Total current assets:124208231306309618337
Noncurrent Assets
Property, plant and equipment41313161578
Long-term investments and receivables712   74
Long-term investments712   74
Intangible assets, net (including goodwill)6166927949021,0097283
Intangible assets, net (excluding goodwill)6166927949021,0097283
Other noncurrent assets6811870
Deferred tax assets, net   23 76
Total noncurrent assets:6327258089191,05493172
TOTAL ASSETS:7579331,0391,2251,363711509
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:63498990945342
Accounts payable2361515131 
Accrued liabilities33316059638 
Employee-related liabilities     77
Taxes payable  00  62
Interest and dividends payable712131619  
Other undisclosed accounts payable and accrued liabilities     36(27)
Debt8012083    
Customer refund liability6176136132121  
Business combination, contingent consideration, liability  053 
Deferred revenue and credits    3
Other liabilities2141151
Other undisclosed current liabilities      111
Total current liabilities:20624631122722057157
Noncurrent Liabilities
Long-term debt and lease obligation286446544719807230 
Long-term debt, excluding current maturities286446544719807230 
Liabilities, other than long-term debt17201429224525
Deferred revenue and credits    12
Deferred tax liabilities, net    33 
Other liabilities16191318111213
Business combination, contingent consideration, liability1111012 
Total noncurrent liabilities:30346655974782927525
Total liabilities:5087138699751,048332182
Stockholders' equity
Stockholders' equity attributable to parent248220170251315364137
Common stock00314292265240221
Additional paid in capital456403757679770
Accumulated other comprehensive loss (0)(0)(0)(0)(0)(0)
Retained earnings (accumulated deficit)(207)(183)(220)(117)(28)48(84)
Total stockholders' equity:248220170251315364137
Other undisclosed liabilities and equity     14189
TOTAL LIABILITIES AND EQUITY:7579331,0391,2251,363711509

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues213312381456343390134
Revenue, net381456343148116
Cost of revenue(8)(80)(115)(87)(123)(15)(7)
Cost of goods and services sold(1)(1)(75)(87)(68)(15)(7)
Gross profit:205232266368220375127
Operating expenses(222)(188)(308)(344)(270)(138)(118)
Other undisclosed operating income     00
Operating income (loss):(17)44(42)25(50)2379
Nonoperating income (expense)01(62)(89)(73)(24)(5)
Investment income, nonoperating 110101
Other nonoperating expense(3)      
Interest and debt expense(22)(69)(6)(6)(73)(9)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(38)(24)(110)(70)(197)2044
Other undisclosed income (loss) from continuing operations before income taxes(17)62667391
Income (loss) from continuing operations before income taxes:(54)38(104)(65)(123)2135
Income tax expense (benefit)6(1)1(24)47(81)39
Net income (loss) available to common stockholders, basic:(49)37(102)(89)(76)13243
Interest on convertible debt     4 
Other undisclosed net loss available to common stockholders, diluted(16)      
Net income (loss) available to common stockholders, diluted:(65)37(102)(89)(76)13643

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(49)37(102)(89)(76)13243
Comprehensive income (loss):(49)37(102)(89)(76)13243
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0) 00(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(49)37(102)(89)(76)13243

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: